Correction: Walking pace, handgrip strength, age, APOE genotypes, and new-onset dementia: the UK Biobank prospective
Panpan He1,2,3,4, Chun Zhou1,2,3,4, Ziliang Ye1,2,3,4
1Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Alzheimer'S Research & Therapy
|April 4, 2023
Abstract
No abstract available in PubMed .
Related Concept Videos
01:26Alzheimer's Disease: Overview
557
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
557
01:30Dementia
150
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
150